Guest guest Posted October 17, 2002 Report Share Posted October 17, 2002 atracyphd wrote: My Groups | drugawareness Main Page Ireland has just requested that GlaxoSmithKline recall Paxil in that country because it failed to warn of suicidal behavior connected to the drug. Finally a country willing to stand up for those being slaughtered by this company with this deadly drug!!!! Obviously the Irish Medicines Board has far more integrity than the FDA in this country. For years I have warned that this is one of the most powerful and most deadly of the SSRI antidepressants, the Prozac family of drugs, because of its strong effect upon the reuptake of serotonin. How anyone can even take it is beyond me considering the horrific headaches it causes as you begin to take the drug. This is wonderful news! The BBC's wonderful piece on Paxil this Sunday, called the Secrets of Seroxat [Paxil in the US], exposed much that has been hidden for 15 years about this drug and indicated that much is still being kept from the public. If you have not seen the show yet I would highly recomend it and encourage you to come to our site at www.drugawareness.org to access the show online and view this excellent expose on Paxil. Dr. Ann Blake Tracy, Executive Director, International Coalition For Drug Awareness www.drugawareness.org and author of Prozac: Panacea or Pandora? - Our Serotonin Nightmare (800-280-0730) http://quote.bloomberg.com/fgcgi.cgi?mnu=news & ptitle=Top%20Stories%20Europe & tp=ad_uknews & T=news_storypage99.ht & ad=euro & s=APa1yWxaJR2xheG9T Top Stories Europe 10/16 15:06 GlaxoSmithKline Told to Recall Antidepressant Drug in Ireland By Thomas Molloy Dublin, Oct. 16 (Bloomberg) -- Ireland told GlaxoSmithKline Plc to recall one of its most prescribed drugs because a patient leaflet for the Irish market fails to warn about possible suicidal behavior, the Irish Medicines Board said. The U.K. pharmaceuticals company has been ordered to recall all stocks of the antidepressant drug Seroxat stored by wholesalers, the board said. The Irish Medicines Board, which controls the sale of medicines in Ireland, asked GlaxoSmithKline to change the leaflets at the end of 2001. Glaxo responded by adding new wording warning patients that suicidal thoughts may increase in the first few weeks of treatment, the board said. The Brentford, England-based company has now been told to ``revise the wording on the license and patient information leaflets to include a reference to suicidal behavior and depression,'' the board said in the statement. Shares in GlaxoSmithKline fell 19 pence, or 1.4 percent, to 1,357p at 3:04 p.m. local time in London. Seroxat, also known as Paxil, is one of GlaxoSmithKline's most prescribed drugs, with sales of $2.7 billion last year. It's part of a class of treatments known as selective serotonin re- uptake inhibitors, which the U.S. Food and Drug Administration doesn't consider habit-forming. Last year, a jury in federal court in Wyoming said Glaxo should pay $6.4 million to the relatives of a man who went on a shooting rampage, killing his family and then himself after taking Seroxat. At the time, Glaxo said it would appeal. Martin Sutton, a spokesman for GlaxoSmithKline in London, declined to comment, saying the company would issue a statement later today. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 19, 2002 Report Share Posted October 19, 2002 Yes, but think of all the people in Ireland who are addicted to Paxil, and who will now have major withdrawal effects from the recall. It isn't just it's potential side effects for suicide, but the fact that many people find it impossible to withdraw from, and although the pharmaceutical companies have covered that up, it's been uncovered through litigation. So what will happen with all the Paxil addicts? Linda Jones lindaj - " Frank " <califpacific <gettingwell > Wednesday, October 16, 2002 6:43 PM Re: [drugawareness] IRELAND DEMANDS GLAXO TO RECALL PAXIL!!! > > > atracyphd wrote: > > My Groups | drugawareness Main Page > > Ireland has just requested that GlaxoSmithKline recall Paxil in that country because it failed to warn of suicidal behavior connected to the drug. Finally a country willing to stand up for those being slaughtered by this company with this deadly drug!!!! Obviously the Irish Medicines Board has far more integrity than the FDA in this country. > > For years I have warned that this is one of the most powerful and most deadly of the SSRI antidepressants, the Prozac family of drugs, because of its strong effect upon the reuptake of serotonin. How anyone can even take it is beyond me considering the horrific headaches it causes as you begin to take the drug. > > This is wonderful news! The BBC's wonderful piece on Paxil this Sunday, called the Secrets of Seroxat [Paxil in the US], exposed much that has been hidden for 15 years about this drug and indicated that much is still being kept from the public. If you have not seen the show yet I would highly recomend it and encourage you to come to our site at www.drugawareness.org to access the show online and view this excellent expose on Paxil. > > Dr. Ann Blake Tracy, Executive Director, > International Coalition For Drug Awareness > www.drugawareness.org and author of Prozac: Panacea or Pandora? - Our Serotonin Nightmare (800-280-0730) > > > http://quote.bloomberg.com/fgcgi.cgi?mnu=news & ptitle=Top%20Stories%20Europe & tp=ad_uknews & T=news_storypage99.ht & ad=euro & s=APa1yWxaJR2xheG9T > > Top Stories Europe > 10/16 15:06 > > GlaxoSmithKline Told to Recall Antidepressant Drug in Ireland > > By Thomas Molloy > > Dublin, Oct. 16 (Bloomberg) -- Ireland told GlaxoSmithKline Plc to recall one of its most prescribed drugs because a patient leaflet for the Irish market fails to warn about possible suicidal behavior, the Irish Medicines Board said. > > The U.K. pharmaceuticals company has been ordered to recall all stocks of the antidepressant drug Seroxat stored by wholesalers, the board said. > > The Irish Medicines Board, which controls the sale of medicines in Ireland, asked GlaxoSmithKline to change the leaflets at the end of 2001. Glaxo responded by adding new wording warning patients that suicidal thoughts may increase in the first few weeks of treatment, the board said. > > The Brentford, England-based company has now been told to ``revise the wording on the license and patient information leaflets to include a reference to suicidal behavior and depression,'' the board said in the statement. > > Shares in GlaxoSmithKline fell 19 pence, or 1.4 percent, to 1,357p at 3:04 p.m. local time in London. > > Seroxat, also known as Paxil, is one of GlaxoSmithKline's most prescribed drugs, with sales of $2.7 billion last year. It's part of a class of treatments known as selective serotonin re- uptake inhibitors, which the U.S. Food and Drug Administration doesn't consider habit-forming. > > Last year, a jury in federal court in Wyoming said Glaxo should pay $6.4 million to the relatives of a man who went on a shooting rampage, killing his family and then himself after taking Seroxat. At the time, Glaxo said it would appeal. > > Martin Sutton, a spokesman for GlaxoSmithKline in London, declined to comment, saying the company would issue a statement later today. > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.